Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteersSTEAD, Richard B; LAMBERT, John; WESSELS, Dawie et al.Blood. 2006, Vol 108, Num 6, pp 1830-1834, issn 0006-4971, 5 p.Article

A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell AplasiaMACDOUGALL, Lain C; ROSSERT, Jerome; CASADEVALL, Nicole et al.The New England journal of medicine. 2009, Vol 361, Num 19, pp 1848-1855, issn 0028-4793, 8 p.Article